STRC Research

Tag: otof

8 items with this tag.

  • Sep 10, 2026

    Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.

    • strc
    • cochlea
    • aav
    • hearing-loss
    • gene-therapy
    • hair-cell
    • otof
  • Aug 08, 2026

    Erratum: Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness.

    • strc
    • aav
    • gene-therapy
    • otof
  • Aug 05, 2026

    Lunsotogene Parvec: First Approval.

    • strc
    • cochlea
    • aav
    • hearing-loss
    • hair-cell
    • otof
  • Jul 18, 2026

    Restoration, Not Bypass: Otoferlin Gene Therapy and a New Era in Hearing Loss Treatment.

    • strc
    • cochlea
    • aav
    • hearing-loss
    • gene-therapy
    • otof
  • Jul 13, 2026

    In vivo-directed evolution identifies AAV-WM04 as a next-generation vector for potent and sustained hearing restoration in DFNB9.

    • strc
    • cochlea
    • aav
    • hearing-loss
    • gene-therapy
    • hair-cell
    • otof
  • Apr 24, 2026

    2024-lv-aav1-otof-lancet-trial

    • strc
    • paper
    • aav
    • otof
    • dfnb9
    • clinical-trial
    • dual-vector
    • cochlear-injection
    • h03
    • calibration
  • Apr 15, 2026

    OTOF Clinical Trials 2025 Dual-AAV Validation

    • strc
    • gene-therapy
    • hearing-loss
    • otof
    • clinical-trials
    • dual-aav
  • Apr 14, 2026

    Gene Therapy for Infants and Children With Otoferlin-Related Auditory Neuropathy Spectrum Disorder

    • gene-therapy
    • hearing-loss
    • otoferlin
    • otof
    • auditory-neuropathy
    • clinical-trial
    • pediatric
    • fda-pathway

Created with Quartz v4.5.2 © 2026

  • STRC marketing
  • Egor Lyfar
  • Contact